Drug intelligence / Profile preview

HM12460A

Development stage
Phase 1
Lead developer
Hanmi Pharmaceutical
Modality
Peptides, Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
Administration
Subcutaneous
01

Overview

HM12460A (also known as LAPS-Insulin) is a long-acting basal insulin analog developed by Hanmi Pharmaceutical using its proprietary LAPSCOVERY (Long-Acting Protein/Peptide Discovery) platform. This technology extends the half-life of the insulin molecule by conjugating it to a human immunoglobulin Fc fragment via a non-peptidyl linker, allowing for once-weekly subcutaneous administration. It is intended for the treatment of type 1 and type 2 diabetes mellitus by providing sustained glucose-lowering effects and potentially reducing the risk of hypoglycemia compared to daily basal insulins. Development was previously partnered with Sanofi, but rights were returned to Hanmi in late 2016.

Other names
LAPS-InsulinLAPSInsulin
02

Targets

INSR (Insulin receptor)

Beyond the preview

Go deeper on HM12460A.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HM12460A.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call